- Home
- Clinical Trials
Atopic Dermatitis Studies Kapiti 06
Atopic Dermatitis Studies
Kapiti
Do you struggle with Atopic Dermatitis (Eczema)?
If you experience moderate-to-severe atopic dermatitis (eczema) that isn’t fully controlled with your current treatment, you may be eligible to join a clinical research study investigating a new treatment that may potentially benefit your symptoms and quality of life.
By taking part, you may receive a potential new treatment option for AD , receive regular health checks, and contribute to medical research that could benefit people in the future.
Description
What to expect
Study details
Ages
18 to 70 years old
Duration
The study lasts up to 49 weeks, with up to 19 scheduled clinic visits
Compensation
Participants will be compensated up to $5,700
Eligibility Criteria
You may qualify for this study if you:
- Are 18 to 70 years old
- Have been diagnosed with atopic dermatitis (eczema) for at least 12 months
- Have moderate-to-severe eczema
- Are willing to stop your current treatment for the duration of the research study
Other eligibility criteria do apply. A member of our team can determine if this study is a good fit for you.
Locations
Description
Atopic dermatitis, also known as eczema, is a chronic skin condition that can make your skin feel dry, itchy, and sore. It can come and go, showing up as red, irritated patches that may make daily life uncomfortable and have an impact on sleep, physical comfort and self-confidence.
Flare ups of symptoms can be caused by a wide-range of triggers including changes in temperature, allergens in the environment or food, stress, certain clothing or fabrics and hormonal changes. With eczema, your skin’s protective layer is a bit weaker, which makes it more susceptible to irritants.
Current treatments include topical creams and corticosteroids, but these options don’t always provide lasting relief creating a need for a more effective treatment.
This study is exploring whether a new investigational treatment could help people living with moderate-to-severe atopic dermatitis (eczema) by targeting the underlying inflammation that causes itching and skin irritation.
Researchers are assessing whether this potential new treatment can lessen the severity of eczema symptoms, strengthen the skin’s natural barrier, and provide lasting relief to improve comfort and wellbeing.
What to expect
Participants will be randomly assigned to receive one of two dose levels of the investigational treatment or a placebo. The study treatment is given once every four weeks over a 12-week period.
You will visit the clinic regularly for health assessments, including skin evaluations, physical examinations, and general checkups. Your safety and well-being will be closely monitored by a professional clinical team.
Why join this clinical research study?
- Recieve a new potential treatment for AD at no cost
- Be part of medical research aiming to improve treatment options for eczema
- Learn to better manage your condition
- Receive health checks and advice from our professional medical team
Your privacy is important and all personal information will be kept strictly confidential.
Register your interest today.
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
Momentum Clinical Research NZ is a member of the Global Site Holdings Group. Global Site Holdings Pty Limited ACN 668 977 062 trading as Momentum Clinical Research ABN 51 668 977 062 and our related entities (we, us, our), will use the Personal Information you have provided in the above form to review and respond to your enquiry, to contact you about any future trials or studies you may be eligible for, and otherwise in accordance with our Privacy Policy and as required and authorised by law. We may not be able to provide you with a complete response or a response at all to your enquiry if you do not provide the requested information. Our Privacy Policy also contains further information about how we collect, use, store or disclose your Personal Information, how you may seek access and correction of your Personal Information, and how you may make a complaint about a breach of privacy. If you have questions, please contact us at contact@momentumclinicalresearch.com.